American Renal Associates Holdings Inc. said Wednesday it priced its initial public offering of 7.5 million shares at $22.00 a share, at the higher end of the expected pricing range of $20 to $23. The provider of dialysis services also granted the underwriters the option of purchasing an additional 1.13 million shares at the IPO price. American Renal is expected to begin trading on the New York Stock Exchange on Thursday under the ticker ARA. Bank of America Merrill Lynch, Barclays and Goldman Sachs & Co. are serving as lead joint book-running managers.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
